Johnson & Johnson To Supply Up To 400 Mln Doses Of COVID-19 Vaccine Candidate To Africa

(RTTNews) - Drug maker Johnson & Johnson (JNJ) announced its agreement to provide up to 400 million doses of its single-shot Covid-19 vaccine candidate to African Union's 55 member states.

Further, Johnson & Johnson, as announced earlier, expects to enter into an Advance Purchase Agreement or APA with Gavi, the Vaccine Alliance in support of the COVAX Facility, to provide up to 500 million doses of the vaccine to COVAX through 2022. In December 2020, the company had entered into an agreement in principle with Gavi.

COVAX supports the initial vaccination needs of 190 participating economies, including many countries in Africa.

Johnson & Johnson expects to provide its single-shot COVID-19 vaccine candidate on a not-for-profit basis for emergency pandemic use.

Alex Gorsky, Chairman and Chief Executive Officer of J&J said, "From the beginning of this pandemic, Johnson & Johnson has recognized that no one is safe until everyone is safe, and we have been committed to equitable, global access to new COVID-19 vaccines."
See also:
Leave a comment
  • Latest
  • Read
  • Commented
Calendar Content
«    Август 2022    »